Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID - Vigipallia

0 avis

Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID

Archive ouverte

Caron, Benoît | Peyrin-Biroulet, L. | Nachury, M. | Bouhnik, Y. | Seksik, P. | Bouguen, G. | Caillo, L. | Laharie, D. | Carbonnel, F. | Altwegg, R. | Reenaers, C. | Serrero, M. | Boureille, A. | Nancey, S. | Filippi, J. | Abitbol, V. | Savoye, G. | Vuitton, L. | Viennot, S. | Fumery, Mathurin | Reymond, M. | Bronowicki, J. P. | Reimund, J. -M. | Amiot, A.

Edité par CCSD ; Elsevier - Oxford University Press -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study

Archive ouverte | Poullenot, F. | CCSD

International audience

The real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study

Archive ouverte | Amiot, A. | CCSD

International audience

Validation of IBD-disk for the assessment of daily-life burden of patients with inflammatory bowel disease

Archive ouverte | Tadbiri, S. | CCSD

International audience

Chargement des enrichissements...